Wellspect HealthCare Expands Surity™ Portfolio in the U.S. with Surity™ Male External Catheter for Urinary Incontinence Care
Wellspect HealthCare, a subsidiary of Dentsply Sirona, launched the Surity Male External Catheter in the U.S. to address urinary incontinence in men. The non-invasive device is designed for up to 24 hours of wear and complements the previously released female version, with a full urinary management system anticipated soon.
Key figures
- Affected population us
- more than 13 million Americans
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.